If you have Crohn’s disease or ulcerative colitis, then you know how hard it can be to pay for your medication. A Foundation study found that people with inflammatory bowel disease (IBD), especially Crohn’s, pay three times the total health care costs and double the out-of-pocket expens...

Ever wonder what fecal microbiota transplantation is? Check out our latest vlog featuring Dr. Neil Nandi, Director of the Inflammatory Bowel Disease Center at Drexel University, College of Medicine. Video Length ...

On May 30th of this year, the Food and Drug Administration (FDA) approved a new treatment for moderately to severely active ulcerative colitis.  Tofacitinib, which is made by Pfizer Labs, was previously approved in 2012 for rheumatoid arthritis and in 2017 for psoriatic arthritis. The ...